Can you stay on 2.5mg Mounjaro forever — or does the dose always have to go up?

Why the 2.5mg dose exists, and what it isn't designed to do

When tirzepatide was studied in the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants who reached 15mg lost an average of around 20–21% of their body weight over 72 weeks. That result came from people who titrated through the full licensed schedule, not from people who stayed at the lowest strength. The 2.5mg starting dose simply wasn't the variable being studied for effectiveness; it was the adjustment period before the therapeutic work began.

The prescribing information is explicit on this point. The 2.5mg weekly dose is described as an initiation dose to improve tolerability. Your gut slows somewhat, appetite signals shift, and nausea is most likely in the first few weeks. Starting low is how those effects are kept manageable. Once the body has adjusted (usually across the first four weeks) the schedule calls for a step up to 5mg.

So if you're wondering whether staying at 2.5mg indefinitely would still produce the appetite reduction and weight change the medicine is known for, the honest answer from the clinical evidence is: probably very little. The dose that settles your system is not the same dose that does the heavier lifting. Our Mounjaro treatment overview has more on how the full titration schedule works in practice.

What happens if going up feels difficult, the clinical picture

Some people find moving from 2.5mg to 5mg brings a return of nausea or digestive discomfort they thought had passed. That's real, and it's a conversation worth having with your prescriber rather than simply staying put. Slowing the titration pace is different from stopping it altogether, a prescriber might suggest extending the time at one dose before stepping up, rather than abandoning progression entirely.

The NHS patient information for tirzepatide notes that gastrointestinal side effects (nausea, loose stools, indigestion) are most common when starting or after a dose increase, and typically settle within a couple of weeks. That pattern is part of why the titration steps exist: each one gives your body another settling-in window.

There are situations where a prescriber might hold someone at a particular dose for longer than the standard interval, but this is an active clinical decision made with knowledge of your full picture. It isn't the same as simply staying at 2.5mg on the basis that it feels comfortable. If you want to understand whether staying on 2.5mg of Mounjaro is a realistic long-term option, that page works through the clinical reasoning in detail. If you're weighing up the differences between doses and how they compare, the question of staying at 5mg longer-term involves a different set of evidence and considerations.

What NICE guidance assumes about therapeutic dosing

NICE recommended tirzepatide for weight management in England in December 2024 (Technology Appraisal TA1026), setting out that treatment should be reviewed if less than 5% of body weight is lost after six months at the highest tolerated dose. That framing assumes patients are working through the titration schedule to find their highest tolerated dose, not remaining at the floor of it. The guidance also notes that if a response isn't being seen, continuing may not be appropriate. Staying indefinitely at 2.5mg would make that six-month assessment largely meaningless, since 2.5mg isn't expected to produce the weight-loss response the review is looking for.

The cost of treatment is a fair consideration when you're thinking through whether to continue at any dose. Our Mounjaro cost page sets out what private treatment involves in terms of transparent pricing. At nume, at nume, there are no hidden fees and no automatic renewals, and every repeat order is clinically reviewed before it's approved, which means your prescriber is looking at your progress each time.

Stepping back: what makes a dose the right one for you

The right maintenance dose is the highest one you tolerate well and that's producing a meaningful response for you, somewhere between 5mg and 15mg for most people, based on the clinical trial programme involving thousands of adults across the SURMOUNT studies. There's no universal answer, which is exactly why titration is prescriber-led rather than self-directed.

If you're already on Mounjaro and feeling uncertain about where you are in the schedule, your prescriber and the Patient Information Leaflet that came with your pen are the right starting points. The pen itself arrives in plain, unbranded packaging via DPD with tracking, and inside it every detail (including the storage window and what to do if you miss a dose) is covered in the leaflet. That's the document to reach for when you have questions about your specific situation, alongside your clinical team.

Questions about a different dose? The considerations around staying at 7.5mg are a useful reference point for understanding how mid-range maintenance looks in practice. If you're curious about higher-strength peptide use, our guide to 30mg tirzepatide peptide dosage covers what that level involves and how it differs from the licensed titration schedule. And if you're thinking about starting out, start a free consultation with our prescribers, a real clinician reviews every application the same day, and suitability is always assessed individually.